These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 13737092)

  • 21. Results in the use of triethylene melamine (TEM) in malignant lymphomas and chronic leukemias.
    MEZA ARRAU C; NIJAMKIN A
    Rev Med Chil; 1955 Feb; 83(2):90-5. PubMed ID: 14385308
    [No Abstract]   [Full Text] [Related]  

  • 22. Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate.
    Pfeifer H; Wassmann B; Hofmann WK; Komor M; Scheuring U; Brück P; Binckebanck A; Schleyer E; Gökbuget N; Wolff T; Lübbert M; Leimer L; Gschaidmeier H; Hoelzer D; Ottmann OG
    Clin Cancer Res; 2003 Oct; 9(13):4674-81. PubMed ID: 14581336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple exploitable molecular targets for differentiation therapy of leukemias.
    Tsiftsoglou AS
    Leuk Res; 2008 Jan; 32(1):1-2. PubMed ID: 17629556
    [No Abstract]   [Full Text] [Related]  

  • 24. Eradication of leukemia stem cells as a new goal of therapy in leukemia.
    Ravandi F; Estrov Z
    Clin Cancer Res; 2006 Jan; 12(2):340-4. PubMed ID: 16428470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma cell dyscrasias and leukemias.
    Wiernik PH
    Cancer Chemother Biol Response Modif; 2005; 22():343-89. PubMed ID: 16110620
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party.
    Kataoka I; Kami M; Takahashi S; Kodera Y; Miyawaki S; Hirabayashi N; Okamoto S; Matsumoto N; Miyazaki Y; Morishita Y; Asai O; Maruta A; Yoshida T; Imamura M; Hamajima N; Matsuo K; Harada M; Mineishi S;
    Bone Marrow Transplant; 2004 Oct; 34(8):711-9. PubMed ID: 15361916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulation against leukemias and lymphomas: a realistic future treatment?
    Mittal S; Marshall NA; Barker RN; Vickers MA
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):101-8. PubMed ID: 17719232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Epidemiology of leukemias].
    Troussard X; Collignon A
    Soins; 2008 Mar; (723):36-7. PubMed ID: 18380309
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute leukemias in adults.
    Kolitz JE
    Dis Mon; 2008 Apr; 54(4):226-41. PubMed ID: 18346480
    [No Abstract]   [Full Text] [Related]  

  • 30. [Physiopathology and possible clinical use of hematopoietic stem cells. Recent advances].
    Testa U
    Recenti Prog Med; 2009 Mar; 100(3):144-55. PubMed ID: 19475843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controversies of and unique issues in hematopoietic cell transplantation for infant leukemia.
    Hunger SP; Loh KM; Baker KS; Schultz KR
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):79-83. PubMed ID: 19147083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of FAB classification of acute leukemias in era of immunophenotyping.
    Sachdeva MU; Ahluwalia J; Das R; Varma N; Garewal G
    Indian J Pathol Microbiol; 2006 Oct; 49(4):524-7. PubMed ID: 17183842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cell vaccines for leukemia patients.
    Schmitt A; Hus I; Schmitt M
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):275-83. PubMed ID: 17338648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic leukemias.
    Enright H; Bond J
    Dis Mon; 2008 Apr; 54(4):242-55. PubMed ID: 18346481
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of a gene therapy based bone marrow purging system for leukemias.
    Huang W; Tan W; Zhong Q; Schwarzenberger P
    Cancer Gene Ther; 2005 Nov; 12(11):873-83. PubMed ID: 15891774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.
    Yocum AK; Busch CM; Felix CA; Blair IA
    J Proteome Res; 2006 Oct; 5(10):2743-53. PubMed ID: 17022645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia.
    Aversa F; Reisner Y; Martelli MF
    Blood Cells Mol Dis; 2004; 33(3):294-302. PubMed ID: 15528148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double leukemias simultaneously showing lymphoblastic leukemia of the bone marrow and monocytic leukemia of the central nervous system.
    Ikarashi Y; Kakihara T; Imai C; Tanaka A; Watanabe A; Uchiyama M
    Am J Hematol; 2004 Mar; 75(3):164-7. PubMed ID: 14978698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary leukemias in refractory germ cell tumor patients undergoing autologous stem-cell transplantation using high-dose etoposide.
    Houck W; Abonour R; Vance G; Einhorn LH
    J Clin Oncol; 2004 Jun; 22(11):2155-8. PubMed ID: 15169802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute leukemias in children with Down syndrome.
    Zwaan MC; Reinhardt D; Hitzler J; Vyas P
    Pediatr Clin North Am; 2008 Feb; 55(1):53-70, x. PubMed ID: 18242315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.